Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

ADNiR Scholars

Congratulations to the 2025 ADNiR Scholars

Cindy An

Cindy is a 2025 ADNiR scholar

Cindy is an ADNiR scholar in the Multifaceted Explorations of the Neurobiology of Depressive Disorders (MEND2) lab under the mentorship of Dr. Mindy Westlund Schreiner and Dr. Scott Langenecker

Cindy is a Neuroscience and Psychology major with a minor in Statistics. Her research interests include using neuroimaging techniques to improve individualized treatment and diagnosis of psychiatric disorders. Cindy is passionate about uncovering the neural underpinnings of negative symptoms and suicidal behavior in psychotic disorders. She hopes to pursue a PhD in clinical psychology to further explore these interests.

 

Vania Gandhi

Vania is a 2025 ADNiR scholar

Vania is an ADNiR scholar in the Aphasia Laboratory with Dr. Stacy Harnish.

Vania is a third-year undergrad student, studying neuroscience on a pre-med track. As a part of the ADNiR program, she hopes to be a part of translational neuroimaging research that can directly improve patient outcomes, particularly for managing mental health and chronic illnesses.


 

2024 recipients

Declan Alford

Declan is a 2024 ADNiR scholar

Declan is an ADNiR scholar in Dr. Hoskinson's lab. 

My name is Declan Alford and I am majoring in psychology. Throughout my undergraduate career, I developed my interest in the intersection between behavioral psychology and neuroimaging research, which led me to apply to the ADNiR program. Through this program, I started working as a research assistant at Hoskinson Laboratory, where I have been able to further cultivate my research interests in this field by participating in neuroimaging data analysis and various study visits. After finishing my undergraduate career, I am planning on continuing to pursue research and either work towards a PhD in behavioral psychology or an MD in psychiatry.

 

Sophie Jeng

Sophie is a 2024 ADNiR scholar

Sophie is an ADNiR scholar in Dr. Hoskinson's lab.

Hello, my name is Sophie Jeng. I am majoring in Psychology with a minor in Pharmaceutical Sciences. After graduation, I look forward to pursuing my PhD in Clinical Psychology, becoming a dual researcher and clinician. My research interests are ever expanding, however, my combined interests in pharmaceuticals, neuroimaging, and patient care have grown my affinity for the functional structures of the brain and its links in behavior.  

 

2023 Recipients

Ajuna Mwesigye

Ajuna is a 2023 ADNiR scholar

Ajuna was an ADNiR scholar on a joint project with Dr. David Osher and Dr. Zeynep Saygin.

He is currently working as a virtual health technician for the University of Colorado Hospital (UCHealth).


 

 

Lingwen Ren

lingwen is a 2023 adnir scholar

Lingwen was an ADNiR scholar in Dr. Fournier's lab.

Lingwen graduated in the spring of 2025.

2022 Recipients

Florencia Ontiveros

Florencia is a 2022 Adnir scholar

Florencia was an ADNiR scholar with Dr. Kristen Hoskinson.

Florencia received her Bachelor of Science in Neuroscience in 2024. She continues to work in Dr. Hoskinson's lab as a Clinical Research Coordinator and has joined Dr. Eric Nelson's lab in the Center for Biobehavorial Health at Nationwide Children's Hospital. She is interested in how pediatric injury and disease impact brain structure and function and how they related to cognitive and behavioral outcomes, especially cognitive abilities like memory. Florencia is currently involved in all aspects of neuroimaging research from recruiting to data analysis and want to pursue a PhD in cognitive neuroscience.

Mengxin (AvA) Ran

Ava is a 2022 Adnir scholar

AvA was an ADNiR scholar in Dr. Golomb's lab.

She is currently a lab manager and research assistant in the FeldmanHall Lab at Brown University. The lab studies how we adaptively navigate our social worlds. AvA is focusing on how resources in the environment influence prosocial behavior and how social identity influences political polarization.

 

2021 Recipients

Alexa Shin

Alexa is a 2021 Adnir scholar

Alexa was an ADNiR scholar in Dr. Scott Hayes' lab.

Alexa is currently attending medical school at the University of Toledo. She was awarded a 2024 American Academy of Neurology Medical Student Research Scholarship for her project "Evaluation of Mental Rotation Test (MRT) modified for functional MRI assessment in early onset Parkinson’s disease patients," under the mentorship of Dr. Thyagarajan Subramanian. 

Jessica Timog

Jessica is a 2021 adnir scholar

Jessica was an ADNiR scholar in Dr. David Osher's lab.

Jessica is currently a graduate student at OSU, in the Department of Speech and Hearing Science.

2020 Recipients

Yasemin Gokcen

Yasemin is a 2020 recipient

Yasemin was an ADNiR scholar in Dr. Zeynep Saygin's Lab.

Yasemin is currently a PhD student at the University of California, Merced, in the Cognitive and Information Sciences department working with Dr. David Noelle and Dr. Rachel Ryskin. Her research is focused on the neural mechanisms of context memory and language. In 2024, she was granted an award from the ARCS (Achievement Rewards for College Scientists) Foundation Northern California Chapter, which supports promising graduate students in science, technology, engineering, math and medical research.

Arian Sorani

Arian

Arian was an ADNiR scholar in Dr. Theodore Beauchaine’s lab.

Arian earned his master's degree in clinical research at The Ohio State University in 2024. He studied pharmacovigilance and international and domestic regulatory guidelines for conducting clinical trials.

Arian is currently a regulatory compliance officer at the James Comprehensive Cancer Center where he works with the Food and Drug Administration and Institutional Review Board to provide cancer patients with access to oncology trials.